Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Adult and Adolescent Subjects

NCT03153137 is registered in ClinicalTrials.gov with Actelion as lead sponsor.

NCT NCT03153137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03153137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Adult and Adolescent Subjects
Lead sponsor
Actelion
Phase
Phase 3
Overall status
Completed
Start date
August 14, 2017
Completion date
July 26, 2021
Enrollment
142 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease